Aramis Biotechnologies Funding: $30M Raised, Series A (2024)
Aramis Biotechnologies is based in Quebec City, Quebec, Canada. It has raised $30M in total funding. Latest round: Series A.
Aramis Biotechnologies funding overview
Aramis Biotechnologies is based in Quebec City, Quebec, Canada. Aramis Biotechnologies has raised $30M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2024. The round record for Aramis Biotechnologies runs through 2024; nothing later has been disclosed. Investors on record include Employees, Private Investors, Government of Canada (Strategic Innovation Fund). 3 distinct backers are named across the disclosed rounds.
Aramis Biotechnologies at a glance
Total raised
$30M
Latest round
Series A
Latest round date
December 2024
Headquarters
Quebec City, Quebec, Canada
Notable investors
Employees, Private Investors, Government of Canada (Strategic Innovation Fund)
Frequently asked about Aramis Biotechnologies funding
How much has Aramis Biotechnologies raised?
Aramis Biotechnologies has raised $30M in total disclosed funding across the rounds on record.
Who has invested in Aramis Biotechnologies?
Employees, Private Investors, Government of Canada (Strategic Innovation Fund) are named among the investors backing Aramis Biotechnologies.
What was the latest Aramis Biotechnologies funding round?
The most recent disclosed round is a Series A, announced in December 2024.
Where is Aramis Biotechnologies based?
Aramis Biotechnologies is based in Quebec City, Quebec, Canada.
When did Aramis Biotechnologies last raise?
The last disclosed Aramis Biotechnologies round closed in December 2024 at Series A.
Aramis Biotechnologies totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Quebec City below to benchmark round size and investor mix.
